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Abstract
Pancreatic neuroendocrine tumors of glucagon-producing cells are extremely rare in domestic animals. In this report, we describe
for the first time, to our knowledge, the incidental finding of multiple glucagon-producing neuroendocrine tumors of the pancreas
of a horse. The animal was euthanized due to severe local infection after tooth extraction. On postmortem examination, multiple
white nodules of up to 4 cm in diameter were observed in the pancreas. Histologically, pancreatic nodules had the appearance of
neuroendocrine neoplasms with positive immunoreactivity for glucagon, synaptophysin, chromogranin A, and neuron-specific
enolase. Electron microscopy revealed numerous electron-dense granules, similar to those observed in normal pancreatic alpha
cells, in the neoplastic cells. In addition, the left adrenal gland showed multiple hyperplastic foci and adenomas in the medulla that
were identified as pheochromocytomas. Based on the morphologic appearance and immunohistochemical staining pattern of
pancreatic nodules, a diagnosis of multiple glucagon-producing neuroendocrine tumors was made.
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The neuroendocrine system can be divided into the gland-
forming and the diffuse/disseminated neuroendocrine system
(DNES). The gland-forming group includes the pituitary pars
distalis, parathyroid, paraganglia, and adrenal medulla. Cell
types of the DNES may be found in the pancreas, thyroid, skin,
lung, and thymus, as well as in the bilary, urogenital, and
gastrointestinal tracts.6
Pancreatic neuroendocrine neoplasms (Pan-NENs) in
humans and domestic animals can be divided into 2 groups:
functioning and nonfunctioning neoplasms. Functioning
tumors produce and secrete hormones, thereby inducing
hormonal syndromes (eg, insulinomas, glucagonomas, gastri-
nomas, vasoactive intestinal peptide [VIP]-omas).5,7 Insulino-
mas are frequently observed in older dogs, adult ferrets, and
rarely in cats. These neoplasms are usually multihormonal,
containing cells expressing somatostatin, glucagon, or pancrea-
tic polypeptide.8,11 Glucagonomas are rare in domestic ani-
mals, occurring less frequently than nonfunctional Pan-NENs
and insulinomas in humans.2,5 These tumors can be associated
with diabetes mellitus and superficial necrolytic dermatitis
or necrolytic migratory erythema.1,3 Gastrinomas cause
Zollinger-Ellison syndrome in dogs and humans, but most
gastrinomas are of duodenal origin, since gastrin-producing
cells do not exist in the adult canine or human pancreas.5
VIP-omas are rare in both animals and humans and can cause
diarrhea as part of the Verner-Morrison syndrome in humans.5
Nonfunctioning pancreatic neuroendocrine tumors produce
hormones but do not exhibit appreciable hormonal secretion
or hormone-related syndromes.5,7 Most nonfunctioning tumors
in animals are composed of PP, alpha, or delta cells.5 Nonfunc-
tioning tumors that are composed of cells that exhibit
immunoreactivity for glucagon, for example, are called
glucagon-producing NENs.7
According to the latest human World Health Organization
(WHO) classification, tumors of the gastroenteropancreatic
neuroendocrine system are generally called neuroendocrine
neoplasms (NENs). NENs are divided into the well-
differentiated neuroendocrine tumors (NETs), which are
further subdivided into grade (G) 1 and G2 tumors, and poorly
differentiated neuroendocrine carcinomas (NECs), which are
considered G3 tumors. Tumor grades 1 to 3 increase in order
of increasing proliferative activity.7 Islet-cell tumors in
1 Institute of Veterinary Pathology, Center for Clinical Veterinary Medicine,
Ludwig-Maximilians-University, Munich, Germany
2 Veterinary Clinic Gessertshausen, Gessertshausen, Germany
Corresponding Author:
N. Herbach, Institute of Veterinary Pathology, Center for Clinical Veterinary




2014, Vol. 51(3) 607-611





veterinary medicine are classified as adenomas or carcinomas.
The benign adenomas tend to appear solitary in dogs and cats
and multiple in ferrets and cattle. Carcinomas are malignant
neoplasms that are characterized by infiltration into surround-
ing tissue, blood vessels, and/or lymphatics. They may metas-
tasize to regional lymph nodes or to the liver and show a high
proliferative index as well as areas of hemorrhage and
necrosis.5
The present study describes the incidental finding of multi-
ple pancreatic glucagon-producing neuroendocrine neoplasms/
adenomas, which, to our knowledge, has not been previously
reported in the horse.
Immunohistochemistry was performed on paraffin-
embedded tissue sections. Antigen retrieval was performed
using proteinase K (synaptophysin) or microwave pretreatment
with citrate buffer (pH 6.0) for 20 minutes (chromogranin A).
Primary antibodies used for immunohistochemistry included
rabbit anti–chromogranin A (1:500 in phosphate-buffered sal-
ine [PBS], pH 7.4; Dako Deutschland GmbH, Hamburg,
Germany), rabbit anti–neuron-specific enolase (1:500 in PBS;
Biomol GmbH, Hamburg, Germany), rabbit anti-synaptophysin
(1:100 in PBS; Dako), guinea pig anti–porcine insulin (1:2000
in PBS; Dako), rabbit anti–human glucagon (1:500 in PBS;
Dako), rabbit anti–human somatostatin (1:300 in PBS; Dako),
or rabbit anti–human pancreatic polypeptide (1:700 in PBS;
Dako), respectively. A biotinylated secondary antibody was used
to detect antibodies against chromogranin A, neuron-specific
enolase, and synaptophysin, using the avidin-biotin complex
method (VECTOR Laboratories Ltd, Peterborough, UK), and a
peroxidase-conjugated secondary antibody was used to detect
antibodies against insulin, glucagon, somatostatin, and PP
(Dako); DAB served as chromogen.
Samples for electron microscopy were postfixed in 1%
osmium tetroxid and routinely embedded in Epon. Ultrathin
sections (70–80 nm) were stained with uranyl citrate and lead
citrate and examined with a transmission electron microscope
(EM10; Zeiss, Oberkochen, Germany).
The 23-year-old Württemberger crossbred gelding was
euthanized due to severe local infection following tooth extrac-
tion. Postmortem examination revealed severe necrotizing
inflammation of the alveolar bone surrounding the extracted
tooth as well as adjacent skin, muscles, and connective tissue
of the head, the frontal, maxillary, and conchal sinuses, cranial
nerves, pituitary and pineal glands; and the ventral meninges.
Microbiological examination revealed a mixed flora consisting
of Staphylococcus aureus, Escherichia coli, Candida spp,
Aspergillus fumigatus, and Mucoraceae in the alveole, sinuses,
and the meninges. In addition, bacteria-containing thrombi
were observed in histological sections of the lungs, indicating
hematogenous spread.
The pancreas contained multiple, well-circumscribed, round
nodules measuring 0.2 to 4 cm in diameter that were white on
section with focal hemorrhage and necrosis in larger masses
(Fig. 1). Histologically, the masses were identified as neo-
plasms surrounded by a fibrous capsule, a trabecular or gland-
ular arrangement of neoplastic cells, and only occasional
Zellballen formation (Fig. 3). The tumor cells were well
differentiated and uniform, showing a lightly eosinophilic to
amphophilic granular cytoplasm, round to oval nuclei and
inconspicuous nucleoli (Figs. 2–4). The mitotic index was low
(<10 per 2 mm2). In some tumors, multifocal hemorrhage and
necrosis corresponded to grossly observed cystic areas.
Neoplastic cells showed moderate diffuse cytoplasmic
immunoreactivity for glucagon (Fig. 5), the neuroendocrine
markers synaptophysin (Fig. 6) and chromogranin A, and
strong diffuse cytoplasmic immunoreactivity for neuron-
specific enolase (not shown). Tumor cells were negative for
insulin (Fig. 7), somatostatin, and PP (not shown).
Besides glucagon-producing tumors, multifocal areas of
alpha-cell hyperplasia could be detected in the pancreas by
immunohistochemistry, and in addition, physiologically sized
islets also contained numerous alpha cells (Fig. 5), apart from
numerous insulin-producing cells and very few delta and PP
cells (not shown).
Electron microscopically, numerous electron-dense gran-
ules measuring about 230 to 400 nm in diameter could be
detected in the tumor cells, similar to secretory granules com-
monly seen in alpha cells associated with glucagon storage
(Fig. 8).
According to histological, immunohistochemical, and elec-
tron microscopic findings and due to the lack of a clinically overt
hormonal syndrome, the diagnosis of multiple glucagon-
producing NETs (human WHO) or nonfunctional alpha-cell
adenomas (veterinarian WHO classification) was made.
In addition, multiple red or beige tumors were observed in
the medulla of the left adrenal gland. Histology and immuno-
histochemistry revealed multifocal hyperplasia of the adrenal
medulla and multiple pheochromocytomas (not shown).
Nonfunctioning Pan-NENs may produce large amounts of
hormones but, by definition, are considered nonfunctional
because these hormones are not secreted or do not produce a
clinical syndrome. In the presented case, a nonfunctioning
Figure 1. Pancreas; horse. Pancreatic tumor of 4 cm in diameter,
showing a white cross section, multifocal areas of hemorrhage, and
necrosis; the arrow indicates a microadenoma of 2 mm in diameter.
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Figure 2. Pancreas; horse. Islet-cell tumor showing a fibrous capsule, with well-differentiated tumor cells arranged in a trabecular or glandular
pattern. Hematoxylin and eosin (HE). Figure 3. Pancreas; horse. Islet-cell tumor with a well-developed fibrous capsule, trabecular or glandular
arrangement of neoplastic cells, and focal Zellballen formation. HE. Figure 4. Pancreas; horse. Islet-cell tumor with glandular arrangement of
neoplastic cells. The tumor cells are uniform, with a lightly eosinophilic to amphophilic granular cytoplasm, round to oval nuclei, and inconspic-
uous nucleoli. HE. Figure 5. Pancreas; horse. Islet-cell tumor, with moderate, diffuse, cytoplasmic immunoreactivity of neoplastic cells for glu-
cagon; hyperplasia of alpha cells in islets (left). Immunohistochemistry, anti–glucagon antibody, hematoxylin counterstain. Figure 6. Pancreas;
horse. Islet-cell tumor, with moderate, diffuse, cytoplasmic immunoreactivity of neoplastic cells for synaptophysin. Immunohistochemistry, anti–
synaptophysin antibody, hematoxylin counterstain. Figure 7. Pancreas; horse. Islet-cell tumor, with no immunoreactivity of neoplastic cells for
insulin and a physiologically sized islet with strong, cytoplasmic staining of beta cells. Immunohistochemistry anti–insulin antibody; hematoxylin
counterstain.
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Pan-NEN was diagnosed due to the lack of clinical signs asso-
ciated with glucagonoma syndrome, such as diabetes mellitus
and skin lesions. Serum chemistry data were not available, but
hyperglycemia due to hyperglucagonemia was considered
unlikely in this horse.
Nonfunctioning Pan-NENs are generally detected during the
life of an animal due to signs produced by tumor mass effect or
on postmortem examination as incidental findings.2,5 Since
nonfunctioning Pan-NENs do not tend to produce hormone-
based clinical syndromes, the incidence of these tumors in
domestic animals is unknown. Most cases diagnosed in vivo
are malignant and produce clinical disease secondary to wide-
spread metastasis.5 Multiple malignant, most likely nonfunc-
tional insulin-producing Pan-NENs have been reported in
cattle. Interestingly, all cattle with multiple tumors also exhib-
ited unilateral pheochromocytoma, as we observed in this
case.4 A jaguar exhibiting 2 glucagon-producing Pan-NETs
without clinical syndrome and no evidence for malignancy was
described,12 and ferrets also have exhibited multiple Pan-NENs,
mainly insulinomas.5 Horses, to the best of our knowledge,
have not been diagnosed with any type of Pan-NEN so far.11 The
pancreata of 165 horses of different age groups were investigated
at the Institute of Veterinary Pathology, LMU Munich between
2009 and 2012. No other primary pancreatic tumors or diseases
were observed by macroscopic investigation of the whole organ
or by histological examination of 5 samples from different ran-
domly chosen regions of the pancreas.
The pancreatic neoplasms of this case showed a predomi-
nantly glandular or trabecular growth pattern. Pan-NETs of
humans and animals may show various arrangements of
neoplastic cells, including solid, trabecular, glandular, pseu-
doacinar, and gyriform.1,2 Interestingly, a predominantly
glandular arrangement of neoplastic cells has been explicitly
described only in humans and dogs so far.2,9
In humans, 60% of all Pan-NETs are nonfunctioning. The
tumors are usually 5 to 6 cm in diameter and frequently malig-
nant, but due to advanced imaging techniques, smaller, non-
functioning tumors are being diagnosed with higher
frequency today.7 Pan-NENs that are classified as nonfunc-
tional in veterinary medicine usually produce PP, glucagon,
or somatostatin (ie, islet hormones that are thought to be less
powerful in producing a clinical syndrome than insulin or gas-
trin).5 In humans, multiple tumors arising from microadenomas
that are smaller than 0.5 cm are rare and usually associated with
multiple endocrine neoplasia 1 (MEN1) or von Hippel–Lindau
syndrome (VHL). Recently, multiple glucagon-producing
tumors, developing from microadenomas (so-called
glucagon-cell adenomatosis), were observed in 4 patients that
were not associated with MEN1 or VHL.7 The tumors were
randomly distributed throughout the pancreas, and patients
exhibited up to 8 macrotumors and up to 600 microtumors. The
tumor cells almost exclusively expressed glucagon, and an
increased fraction of large islets also exhibited a reversed
glucagon-to-insulin ratio,10 similar to the case presented here.
In contrast, in islet-cell hyperplasia of domestic mammals, a
normal distribution of the 4 main endocrine cells is retained.5
In 1 human patient exhibiting glucagon-cell adenomatosis, a
homozygous missense mutation was found in the glucagon
receptor gene that lowered the receptor’s affinity to the ligand
and reduced signal transduction, thereby possibly causing
alpha-cell hyperplasia. An autosomal recessive mode of inheri-
tance of the mutation was suggested.10 In MEN1 and VHL,
endocrine-cell hyperplasia and microadenomas are considered
precursor lesions of Pan-NETs. It was also suggested that
sporadic endocrine hyperplasia, dysplasia, and microadenoma
may give rise to sporadic Pan-NETs,10 which could also be
speculated in the present case.
In summary, this is the first report of multiple glucagon-
producing pancreatic neuroendocrine tumors or nonfunctional
alpha-cell adenomas of a horse, presumably arising from multi-
focal alpha-cell hyperplasia.
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